fda rules on compounded semaglutide If it's not FDA-approved, it's not verified. Before you start or switch to a GLP-1 medication, ask questions. Know exactly what you're taking, how much you're taking, and where it's coming 🚨 FDA Moves to Permanently

Long-term human safety and efficacy are still being investigated

Researchers point to several reasons for this variation, including differences between specific GLP-1 medications, individual mental health history, the presence of eating disorders or mood disorders, and differences in dosage, duration of use, and overall health

The search terms used were glucagon-like peptide 1 receptor agonist, exenatide, liraglutide, dulaglutide, lixisenatide, semaglutide, albiglutide, taspoglutide, loxenatide, diabetes mellitus, obesity and randomized controlled trial

That means the pill will likely be submitted for FDA approval by mid-2026 and potentially approved by later next year or early 2027